Document is current

Any future updates will be listed below

Phase II multicentre study of efficacy and feasibility of dose-intensified preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) in resectable gastroesophageal cancer

Crossref DOI link: https://doi.org/10.1007/s00280-014-2482-0

Published Online: 2014-05-14

Published Print: 2014-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark